Recombinant streptococcal pyrogenic exotoxin C (SPE-C) is a potent superantigen that stimulates VJ32-bearing human T cells, but is inactive in mice. SPE-C binds with high affinity to both human HLA-DR and murine I-E molecules, but not to routine I-A molecules in a zincdependent fashion. Competition binding studies with other recombinant toxins revealed that SPE-C lacks the generic low affinity major histocompatibility complex (MHC) class II (x-chain binding site common to all other bacterial superantigens. Despite this, SPE-C cross-links MHC class II to induce homotypic aggregation of class II-bearing B cells. Nondenaturing sodium dodecyl sulfate electrophoresis and size exclusion chromatography revealed that both wild-type and recombinant SPE-C exist in a stable dimer at neutral or alkaline pH. These data support a recent crystal structure of SPE-C and reveal yet another mechanism by which bacterial superantigens ligate and cross-link MHC class II.
B
acterial superantigens (SAgs) 1 produced by Staphylococcus aureus and Streptococcus pyogenes simultaneously bind to MHC class II antigens and T cell receptor molecules via the V[3 domain and stimulate large numbers of T cells (1) (2) (3) . SAgs stimulate high systemic levels of the proinflammatory cytokines TNF-ot and IL-lJ3 and the T cell mediators IL-2 and INF-'y that cause hypertension, fever, and shock. All SAgs require initial presentation by MHC class II molecules for maximal activity (4) (5) (6) (7) , but the role of the MHC class II molecule appears to differ depending on the SAg. Crystal structures are now available for staphylococcal enterotoxin (SE)A (8) , SEB (9), SEC2 (10) , and toxic shock syndrome toxin (TSST; 11), and although there are significant differences in surface features, each molecule conforms to the same overall folding pattern, with a small N-terminal B-barrel globular domain and a larger COOH-terminal globular domain of the B-grasp motif. Despite conservation of three-dimensional structure, individual staphylococcal and streptococcal SAgs have developed different ways of binding to MHC class II. For example, SEB and toxic shock syndrome toxin TSST-1 both bind to the invariant MHC class II (x chain, but SEB binds out to the side of the (x chain leaving the top of the class II molecule exposed (12) , whereas TSST binds over the top of the class II (x chain and obscures the (x chain ot helix, the peptide, and some of the 1Abbreviations used in thispaper: GST, glutathione S transferase; m, messenger; SAg, superantigen; SE, staphylococcal enterotoxin; SPE, streptococcal pyrogenic exotoxin; TSST, toxic shock syndrome toxin.
[3 chain (x helix (13) . This implies that TCRs, when ligated by TSST, do not contact the MHC class II molecule to which TSST is bound. SEB, on the other hand, appears to rely heavily on continued interaction between TCRs and MHC class II to stabilize a trimeric complex between SEB, MHC class II, and TCR (14) (15) (16) .
Some SAgs, such as SEA, have an additional binding site for the polymorphic J3 chain of MHC class II (17) (18) (19) that is 100 times stronger than (x-chain binding. This interaction results from a tetrameric zinc coordination complex between H187, H225, and D227 of SEA and the highly conserved H81 of the MHC class II [3 chain (17) , and provides SEA with the ability to cooperatively bind and stabilize a second SEA molecule to the low affinity class II c~-chain site, promoting cross-linking of MHC class II molecules on the surface of the APC (17) (18) (19) . Cross-linking of MHC class II is an important component of SEA activity (18, 20) , although the exact mechanism by which this enhances SAg stimulation is not yet known. Experimental evidence indicates that the low aflfinity o~-chain interaction is more important to TCR ligation than MHC class II binding because mutations in this site affect T cell activation without significantly altering class II binding, whereas mutations in the J3-chain site destroy all J3-and (x-chain binding, and subsequent T cell activation (18, 19) .
Despite their role in human disease, the streptococcal toxins have not been as well studied as the staphylococcal toxins. There are three known streptococcal superantigens, streptococcal pyrogenic exotoxin (SPE)-A, SPE-C (21), and SSA (22) . SPE-A and SSA are most similar in sequence to SEB, whereas SPE-C shares little similarity to any other member of the SAg family, and is least homologous with TSST. Nevertheless, there is sufficient sequence homology among all of the staphylococcal and streptococcal toxins to suggest that they have evolved from a common ancestral gene and are likely to fold in a similar manner.
This study has examined SPE-C in detail and reveals unique features that distinguish it from other superantigens. Like TSST, SPE-C is a powerful in vitro activator of human VI32-bearing T cells with a potency approaching that of SEA. However, recombinant SPE-C is totally inactive against routine T cells. Evidence is presented that shows that SPE-C is a dimer molecule that no longer uses the genetic o~-chain binding site, but instead binds only to the 13 chain of MHC class II by a zinc-mediated mechanism similar to SEA. The conclusions made from these functional data are supported by the recently resolved crystal structure of SPE-C (23).
Materials and Methods
Toxin Purification. All toxins were expressed from the pGEX vector in Escherichia coli as glutathione S transferase (GST) fusion proteins and purified by glutathione chromatography as previously described (24) . Mature toxins were cleaved from GST by trypsin digestion and purified by two rounds of cation exchange chromatography. The first round using carboxymethyl sepharose and the second on a POROS HS (Perceptive Systems, Cambridge, MA) HPLC column. All toxins were resistant to trypsin digestion except SEB which has a single cleavage site in the disulphide loop region. This does not affect SEB activity. Radiolabeling and Cell-binding Experiments. 5 p-g of purified toxin was radioiodinated by the chloramine T method to a specific activity of "~50-100 p.Ci/p~g. Labeled toxin was separated from free iodine on a 1 ml Sephadex G25 (Pharmacia, Piscataway, NJ) column and stored at 1 p-g/ml in 50% glycerol-l% hemaglobin phosphate buffered saline.
Toxin Proliferation
LG-2 cells are a human B lymphoblastoid cell line homozygous HLA-DR1. Cells were harvested in log phase, washed in RPMI/10% fetal calf serum, and suspended at 107/ml of the same medium. For duplicate binding studies using either SEA, TSST, or SPE-C, the 125I-tracer toxin was used at 2 ng/tnl with the addition of 0.01-100 p-g of unlabeled toxin. 106 cells (100 p.1) were added and incubated for 1 h at 37°C. Cells were washed three times with ice-cold medium and centrifuged pellets were counted in a gamma counter. For SEB inhibition studies, 1 p-g/m] of ~25I-SEB was used as tracer due to the much lower affinity that SEB binds to LG-2 cells with, and samples were incubated for 4 h at 37°C before washing and counting. For binding studies to mouse B cells, single cell suspensions ofsplenocytes were pretreated at 5 × 106/ml for 4 d in vitro with 20 p-g/m] lipopolysacharride (Sigma Chemical Co., St. Louis, MO) in 10% FCS-DMEM to generate B cell blasts that were harvested and used for cell binding at 107 cells/tube. Cells were incubated for 1 h at 37°C, and then washed three times in ice-cold medium before gamma counting.
Fluorescence Labeling of SEB. 1 mg (1 mg/ml) SEB in 0.1 M sodium carbonate, pH 8.5, was incubated with 20 p-1 of 5 mg/ml fluorescein isothiocyanate in DMSO (Sigma Chemical Co.) overnight in the dark at room temperature. Fluoresceinated SEB was separated from free FITC on a 1-ml G25 column and stored at 4°C with 0.02% NAN3.
LG-2 cells (6 × 105 cells) were incubated for 2 h at 37°C with shaking with 1 Ixg/ml FITC SEB and a 10-fold serial dilution of unlabeled toxin starting at 0.1 mg/ml. After incubation, cells were washed with 2 × 0.5 ml ice-cold PBS and examined immediately on a FACSCAN ® (Becton Dickinson, San Jose, CA).
TCR V~ Analysis. These were performed as previously described using the reverse dot-blot procedure (24) . In brief, human peripheral blood lymphocytes were incubated at 10S/ml with 1 ng/ml of recombinant toxins for 3 d. The cultures were expanded twofold with medium containing 20 ng/ml IL-2. Cells were harvested at 4 d and RNA made by standard procedures (25) . TCR [3-chain messenger was reverse transcribed using a set of primers specific for a conserved region in all 13-chain genes. Amplification ofa 500-bp V[3 probe was accomplished by an anchor primer to the 5' end of the ]3-chain primers plus a single CI3 region primer. This probe was radiolabeled and reverse blotted to filters containing individual [3-chain genes. Relative changes in individual ~3-chain mRNA were compared to unactivated PBL. Zinc Blots. Recombinant toxins (10 p-g) were incubated in triplicate with 10 p~M EDTA followed by 100 p-M 6sznc1 (New England Nuclear, Boston, MA) in 20 mM Tris, pH 8.0, 10 mM MgC12, 0.15 M NaC1 made zinc free by addition of chelex resin (Sigma Chemical Co.) as previously described (17) . Samples were then dot blotted to nitrocellulose filters using a 96-well dot-blot apparatus. Filters were washed briefly three times with zinc-free buffer, and then autoradiographed. Spots were cut out and counted on gamma counter (Packard Instrs., Meriden CT) to quantify 6SZn bound to each toxin.
Anti-TCR mAb FACS
Nondenaturing SDS Electrophoresis. Toxin samples were incubated in standard Laemmli reducing sample buffer (containing 1% SDS and 10 mM dithiothreitol), and then resolved as normal of a 12.5% acrylamide gel. For denaturing conditions, samples were heated to 100°C for 2 rain before loading. To prevent dimers from dissociating during running, the power was maintained below 2 W (20 mA and 100 V). Some reduced samples were treated with 20 mM iodoacetic acid, pH 7.0, before loading. EDTA was added to some samples at 10 mM.
LG-2 Cell Aggregation Assay. Healthy LG-2 were washed in RPMI-10% FCS, vigorously resuspended at 5 × 105 cells/m] in RPMI-10% FCS and aliquoted as a single-cell suspension to a 96-well flat-bottom plate in a final volume of 100 p-1. Cells in duplicate wells were stimulated by the addition of toxin to ,'J37 nM (l.0 p.g/ml). Aggregation was scored at various time points after 376 SPE-C Structure and Function Values reflect the concentration of recombinant toxin required to produce 50% maximal proliferation. There was no detectable prohferation for SPE-C at the highest concentration tested on murine splenocytes.
incubation at 37°C as the percentage of LG-2 cells in aggregates, and was determined by light microscopy.
Western Blotting of S. pyogenes Strain 2035-derived SPE-C. S. pyogenes strain 2035 was grown under anaerobic conditions in brain heart fusion medium at 37°C for 24 h without shaking. Supernatant proteins were concentrated by sequential (NH4)2SO 4 precipitations, with cuts of <40%, 40-60%, 60--80%, and 80% saturation, and resuspended in 50 mM Tris-1 mM EDTA, pH 7.4, at N500--1,000 times their original concentration, tkecombinant SPE-C or 10 I~1 of the 60-80% (NHa)zSO4-precipitable fraction of 2035 supematant were combined with an equal volume of nonreducing 2% SDS sample buffer and separated by 0.1% SDS-12% PAGE. Denatured samples were heated (95°C) for 2 rain before analysis. Fractions were dialyzed extensively against 25 mM Tris-50 mM NaCI-1 mM EDTA, pH 7.4, to remove salt. After separation by SDS-PAGE, proteins were transferred to a nitrocellulose filter (Hybond-C; Amersham Corp., Arlington Heights, IL) in an electroblotting apparatus using Towbin buffer lacking SDS (25 mM Tris.HC1, pH 8.5-150 mM glycine-10% methanol). The filter was blocked in PBS-0.05% Tween-5% nonfat dried milk powder-0.1% normal rabbit serum and stained with 1:6,000 peroxidase-labeled af~fity-purified rabbit anti-SPE-C immunoglobulin. The peroxidase conjugate was detected on radiographic film by chemiluminescence (ECL; Amersham Corp.) according to the manufacturer's instructions.
Size Exclusion Chromatography. Recombinant SPE-C (2 mg/ mi) was dialyzed at 4°C overnight in 20 mM BisTris-Tris, pH 6.0 or 9.0. 20 Ixl samples were diluted into 100 p~l 50 mM BisTris, pH 6.0, 7.0, 8.0, or 9.0/0.1 M NaC1 and incubated for 1 h at room temperature before separation at 1 ml/min (+0.05 ml/min) on a Superose12 (Pharmacia) high resolution HPLC column attached to a Biocad Sprint (Perceptive Systems) preequilibrated with the respective incubation buffer. Trace chromatograms monitoring Abs280~ ,, pH, and conductivity were all recorded directly and subsequently analyzed for retention times, peak integration, and peak assignment using the on-line Biocad software. Traces were grouped and printed using the stacked trace mode which automatically aligns each trace to the injection point.
Results
All toxins were expressed in E. coli as GST fusion proteins and purified by glutathione agarose affinity chromatography, cleaved with trypsin, and purified by HPLC to a point of apparent homogeneity by SDS-PAGE gel analysis.
To ensure native conformation after expression in E. coli, each recombinant toxin was tested for its potency in the standard 3-d [3H]thymidine assay. All, including SPE-C, were active at concentrations < 1 pg/ml on human T cells ( Table 1 ). The most potent of the recombinant toxins was SPE-C, which gave a half-maximal response of 5 fg/ml and was still active at <0.1 fg/ml. In contrast, SPE-C completely lacked proliferative activity for mouse T cells in all strains tested. No activity was observed above background in any mouse strain, even at the highest concentration of SPE-C tested (100 tzg/ml). By comparison, all other recombinant toxins were active on murine T cells at < 1 ng/ ml (except for SEB on C57B1/6). The prohferative activity varied greatly between strains and toxins ( Table 1) . The half-maximal activity of SEB on BALB/c T cells was 4 pg/ ml, but 10,000 pg/ml for C57B1/6 mice, representing a 2,500-fold difference between the two strains. The most consistently potent toxin on mouse T cells was TSST, which varied in its half-maximal activity from 0.6 pg/ml for C57B1/6 mice to 20 pg/ml for C3H mice.
Amino acid sequence alignment of SEA and SPE-C revealed that SPE-C shared two out of the three zinc coordinating residues present in SEA. Residues H201 and D203 in SPE-C are analogous to H225 and D227 in SEA that form the essential bidentate component found in all solvent exposed zinc sites (8, 26) . This suggested that SPE-C might bind zinc in the same way as SEA. Identification of the third hgand was not obvious from direct sequence alignment because the corresponding residues to SEA-H187 is G161, which is unlikely to act as a zinc hgand. However, three other residues in close proximity to G161 could potentially serve as zinc ligands. These are E159, D164, or H167.
Recombinant SPE-C was tested for its ability to bind radioactive 65Zn in a zinc dot-blot assay alongside recombinant SEA, SEE, SEB, and SPE-A (Fig. 1) . SPE-C bound 6SZn 100 times greater than background and 50-fold higher than either SEB or SPE-A (two toxins that do not require Zn 2+ for superantigen function). SEA bound the highest levels of 6SZn in this assay, whereas both SPE-C and SEE bound approximately half this level. Given that bound 65Zn is determined at nonequilibrium conditions, these differ-
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Li et al. ences reflect a combination o f both the equilibrium conditions, these differences reflect a combination o f both the equilibrium affinity and the off-rate o f zinc for the different toxin binding sites. The importance of zinc to SPE-C activity was examined with direct binding of 1251 SPE-C to human and mouse cells expressing M H C class II (Fig. 2) . SPE-C bound with high affinity to human LG-2 cells (which are homozygous HLA-DP,.1), but binding was completely abolished in the presence of 10 p.M E D T A (Fig. 2 A) . Equivalent binding was seen in M H C class II mice expressed on LPS-activated mouse spleen cells expressing both I-A and I-E (BALB/c I-E b, C 3 H / H e J I-E'). Strains such as C57B1/6, B10M/Sn, and SJL/J B-cell blasts that lack expression o f the I-E[3 chain bound 125I-SPE-C poorly (Fig. 2 B) demonstrating that the primary target for SPE-C was the I-E molecule. M a x i m u m binding of SPE-C to both human and mouse cells was restored by a 10 p,M excess of zinc over the EDTA.
Competition binding experiments between SPE-C and other toxins were performed in an attempt to determine the orientation o f SPE-C on M H C class II. The results of these binding experiments are shown in Fig. 3 . SEA was the only toxin to inhibit 125I-SPE-C binding to LG-2 cells, and was only slightly less competitive than SPE-C itself (Fig. 3 A) . Neither TSST nor SEB inhibited 125[-SPE-C, even in 10,000-fold molar excess. Both SEB and TSST (12, 13) . In the reciprocal experiment, only SEA and SPE-C prevented 12sI-SEA binding (Fig. 3 B) . Neither SEB nor TSST inhibited. Although SEA and SPE-C appeared to bind to M H C class II in a similar fashion, competition experiments using 12sI-SEB revealed important differences (Fig. 3 C) . Even at the highest concentration tested (10 p,g/ml), SPE-C did not inhibit 12sI-SEB binding to LG-2 cells, whereas SEA remained an effective competitor, almost as efficient as SEB itself. The same experiment was performed using F I T Clabeled SEB (Fig. 3 D) 378 SPE-C Structure and Function that SPE-C does not share with SEA the ability to prevent SEB binding and thus is unlikely to bind directly to the MHC class II ot chain. The ability of SPE-C to inhibit TSST binding was also tested (Fig. 3 E) . SPE-C was a strong inhibitor of 125I-TSST binding, a result contrary to the reverse experiment (Fig. 3 A) that showed that TSST did not prevent SPE-C binding.
The human TCR V[3 specificity of recombinant SPE-C was determined by reverse PCR dot-blot analysis (24) and the relative V[3 enrichment compared with that induced by SPE-A or Con A. The results are presented in Table 2 . SPE-C almost exclusively targeted VI32-bearing cells, enriching this particular V[3 mRNA over 30-fold (2-60%). The only other V[3s displaying significant enrichment over the Con A-activated control sample were V[34.1 (2-fold), V1312.5 (9-fold), and V[315 (1.6-fold), which increased from 0.2 to 1.7% (an 8-fold increase). The sum total of all V~s stimulated by SPE-C was 94.4%, suggesting that all the VI3 species targeted were accounted for in the probe panel. (20, 27) . This activity is a direct function of two separate binding sites for MHC class II molecules on SEA and presumably reflects the ability to cross-hnk MHC class II. Mutation of either site in SEA or papain cleavage of LB3.1 into F(ab) fragments abolishes the ability to induce homotypic aggregation. Purified recombinant SPE-C was tested in the LG-2 homotypic aggregation assay and found to be as potent as SEA (Fig. 4) suggesting that SPE-C was also capable ofcross-hnking MHC class II. In contrast, neither recombinant SEB nor SPE-A displayed any aggregation activity consistent with the presence of only a single MHC class II binding site on these molecules. Given that the previous experiments suggested the or-chain binding site was absent in SPE-C, two hypotheses were put forward to account for the presumed class II cross-linking activity of SPE-C. The first was that SPE-C binds to MHC class II via the zinc-mediated 13-chain site and another uni- Figure 6 . Presence of SPE-C dimers in the culture supematant of Streptococcus pyogenes. Concentrated streptococcal culture supernatant was run on a nondenaturing SDS gel and blotted to nitrocellulose. The Western blot was incubated with" an affinitypurified rabbit anti-SPE-C antiserum (1:6,000) and detected by chemiluminescence. Den, boiled in SDS sample buffer; ND, nondenatured and reduced. Figure 5 . Recombinant SPE-C forms stable dimers in solution. Recombinant SPE-C (5 mg/nfl) was incubated in either 50 mM morpholine ethane sulphonic acid/Hepes/acetate buffer, pH 5.0, or 50 mM Tris-BisTris buffer, pH 7.0 or 9.0, with either 1 mM EDTA or 10 mM iodoacetamide. One volume of reducing SDS Laemmli sample buffer was added, and then samples were run on a 12.5% SDS gel without boling at a total of 0.5 W of power. dentified site. The second hypothesis was that SPE-C might form dimers in solution with two identical ~3-chain binding sites. To test the second hypothesis, recombinant SPE-C was examined by nondenaturing SDS-PAGE in an attempt to observe SPE-C oligomers. Homodimers were clearly visible under both reducing and nonreducing conditions, representing >60% o f the total amount of SPE-C loaded (Fig. 5 ). These dimers were absent when the sample was denatured in nonreducing conditions (not shown). One feature o f these dimers was their discrete nature, even in the presence o f 1% SDS and 10 m M dithiothreitol. N o smearing between dimer and m o n o m e r was observed. Another feature o f the SPE-C dimers was their dependence on neutral or alkaline p H for formation. At conditions below pH 6.0, virtually no dimers were detected, whereas at p H 7.0, >60% o f the SPE-C was observed in dimer form. Neither E D T A nor iodoacetic acid (a sulfhydryl alkylating reagent) affected dimer stability, indicating the absence o f covalently disulfide linked homodimers.
Because the SPE-C used for SDS nondenaturing studies was recombinant material stored at high concentration (5 mg/ml), protein dimerization might simply be an artifact o f high protein concentration and/or recombinant expression in E, coil Crude S. pyogenes-derived SPE-C was therefore examined by nondenaturing SDS-PAGE and Western blotring using an afffinity-purified anti-SPE-C rabbit anti-serum (Fig. 6) . Culture supernatant from an overnight growth of S. pyogenes strain 2035 was first concentrated 1,000-fold by ammonium sulfate precipitation because SPE-C was undetectable in the raw culture medium. The concentration o f wild-type SPE-C was estimated at < 1 0 ng/rnl in the raw S. pyogenes culture supernatant and ,'-~10 /~g/ml in the crude concentrated sample. Electroblotting of the SPE-C dimer was not as efficient as the monomer, so the relative monomer/dimer ratios were misleading in these experiments. Nevertheless, SPE-C dimer was readily detected in the crude S. pyogenes culture supernatant at approximately the same proportions as in the recombinant SPE-C, despite differences in both purity and concentration. To analyze the effect of p H on SPE-C under more physiological conditions (i.e., in the absence of SDS), SPE-C was dialyzed overnight at either pH 6.0 or 9.0, and then incubated at varying pHs before separation by size exclusion on a Superose 12 HPLC column (Fig. 7) . The p H 6.0 dialyzed sample separated exclusively in the dimer form (95% by peak integration), irrespective o f the p H of the separating buffer (Fig. 7 A) . In contrast, 50% o f the p H 9.0 dialyzed sample dissociated to the monomer form when the p H was lowered to 7.0 or less (Fig. 7 B) . The apparent molecular weight o f both the dimer and monomer peaks appeared to increase with increasing pH. This manifested in a consistent decrease in retention time proportional to increasing pH.
This was unlikely to be due to decreasing charge interactions between the protein and Superose column media because 0.1 M NaCI was included as a counter ion to prevent such weak ionic interactions. Thus, under normal physiological conditions, the majority o f recombinant SPE-C existed in dimer form that only dissociated to the monomer in the presence of an ionic detergent or after dialysis at elevated pH. This readily explained the apparent M H C class II cross-linking activity o f SPE-C, and moreover, suggested that the dimer had two zinc-containing binding sites.
Discussion
The data presented in this paper demonstrate some unique features o f SPE-C that set it apart from all other bacterial SAg. Most notable are (a) the apparent absence o f the generic M H C class II oL-chain binding site c o m m o n to every other superantigen so far studied and (b) the formation o f stable, noncovalent dimers under normal physiological conditions. The evidence for the absence o f an M H C class II oL-chain binding site in SPE-C is compelling. First, SPE-C does not compete for SEB binding to the M H C class II ot chain, in contrast to SEA, which competes well. Second, amino acid comparison o f SPE-C with SEA and SEB indicate major differences in the [31-[32 Figure 7 . 1Leversibility of SPE-C dimer formation. Recombinant SPE-C (2 mg/ml) was dialyzed overnight in (A) 10 mM BisTrisTris, pH 6.0, or (B) 10 mM BisTris-Tris, pH 9.0. Samples (20 I*l) from each dialysis were incubated for 1 h at room temperature in 100 I~1 50 mM BisTrisTris4).l M NaC1 at either pH 6.0, 7.0, 8.0, or 9.0, and then analyzed by size exclusion chromatography. The exact retention time of each peak was determined with the Perceptive Bincad analysis software and is shown beside each peak. Each trace represents absorbance at 280 nm. The resulting figure was generated from the Perceptive Biocad program using the stacked trace mode. The small peak to the right of the pH 6.0 generated dimer is not monomer, but an SPE-C cleavage product also seen to the right of the pH 9.0 monomer peak.
in SPE-C. Third, in the crystal structure of SPE-C, the genetic MHC class II {x-chain binding site is structurally quite different from either SEA or SEB. As a consequence, SPE-C forms a symmetrical interaction with the same NH2-terminal region of another SPE-C molecule resulting in a dimer with two COOH-terminal domains pointing outwards with two potential zinc-containing B-chain binding sites located at opposite poles of the dimer (23) . Significantly, many of the residues in SPE-C that are analogous to oL-chain binding residues in SEA and SEB (12) are buried in the dimer interface. Both recombinant and wild-type SPE-C form discrete, stable dimers in solution with functional properties consistent with the dimer observed in the SPE-C crystal structure (23) . Although we have not formally proven that the solution dimer is exactly the same as the crystal dimer, it would seem surprising that SPE-C should undergo a significant change from one dimer structure to another during crystal formation, given the apparent stability of the solution form. Analysis of the dimer by nondenaturing SDS electrophoresis (in the presence of 1% SDS) revealed a pH dependence for dimer formation with a midpoint around pH 6-7 and a combination of both dimer and monomer forms above neutral pH. Histidine residues might form part of the solution dimer interface (pK of the free imidazole nitrogen is 6.5) and in the crystal structure, SPE-C H35 and E54 form a fourfold zinc coordination with H35 and E54 from a second SPE-C molecule. SPE-C mutants at these positions are currently being examined to confirm the importance of dimerization to SPE-C function. The role of zinc in dimer formation is not immediately obvious from our solution studies because the addition of EDTA had no effect on 381
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dimer stability. Notably, the crystal structure dimer was initiaUy formed=in the absence of zinc, indicating that it is not essential for dimer formation. Zinc was only seen in this position after soaking the crystal in 50 mM zinc (23) . Currently, we believe that the zinc atom in the crystal dimer interface is merely opportunistic and does not serve any structural or functional role. Analysis of the solution dimer under more physiological conditions revealed that >95% of recombinat SPE-C was in the dimer form and required 1% SDS or mild alkaline treatment before it dissociated to the monomer. Evidence for an alkaline pH effect on the SPE-C structure was visible by size exclusion chromatography with a proportional decrease in column retention time (representing an higher apparent molecular weight) of both the dimer and monomer peaks with increasing pH. It is of special note that the dimer interface in the SPE-C crystal structure is large (>900A2), and is formed from two regions, one made up predominantly ofhydrophobic residues (the larger in surface area) and a second smaller hydrophilic region composed of residues in the 131-]32 loop (23). One possible explanation for the observed features of the SPE-C dimer might be that under normal physiological conditions, the hydrophobic interactions in the dimer interface predominate, but are disrupted by ionic detergent or mild alkaline conditions, thus placing a greater dependence for dimer stability on the pH-sensitive hydrophilic regions of the interface. The zinc-containing B-chain binding site in the SPE-C crystal structure consists of residues H167, H201, and D203 (23). Although we have not formally confirmed by mutagenesis that these residues form the MHC class II [3-chain binding site, its structural similarity to the zinc site of SEA (8) , the finding that EDTA destroys SPE-C binding and the strong cross-competition between SEA and SPE-C suggest that this zinc site coordinates to the MHC class II [3 chain in a similar manner to SEA (17) (18) (19) . In the SPE-C crystal dimer, two putative [3-chain binding sites are at opposite ends of the dimer in an optimum position to ligate two MHC class II molecules (23) . This structure is consistent with the potent APC activation activity observed, suggesting that SPE-C cross-hnks two independent MHC class II molecules via their [3 chains.
The ability of SPE-C to prevent TSST binding despite the absence of an ~x-chain binding site in the former toxin might best be explained by steric hindrance between the two toxins across the top of the MHC class II molecule rather than direct competition for ct-chain sites. In support of this conclusion, SPE-C did not inhibit 125I-TSST binding in the presence of EDTA (not shown). The reciprocal competition experiment showed that TSST did not prevent SPE-C binding. One possible explanation for this might be that TSST binding to MHC class II is more restricted than SPE-C due to a greater dependence on peptide residues (28) . This question will only be resolved by binding studies using a single soluble DR1/peptide combination.
The zinc-mediated binding site in the COOH-terminal domain of SEA, SEE, and SED is a remarkable addition to the generic low affinity MHC class II oL-chain binding of other bacterial superantigens that allows these superantigens to bind to the MHC class II [3 chain despite the extensive polymorphism of this part of the MHC class II molecule. Nevertheless, SEA still requires additional binding to the MHC class II cx-chain site for optimal activity. Multiple combined mutations in the SEA a-chain binding site (SEA-F47S.L48A.Y92A) reduce T cell activity by over 800-fold without significantly altering MHC class II binding affinity (19, 20, 29) . The ability of SEA to cross-link MHC class II on the surface of the APC not only increases the rate of stability of binding, but also increases the effective surface concentration of this superantigen. In addition, by also activating the APC, bivalent superantigens such as SEA also promote cell adhesion (seen clearly as homotypic aggregation) and might also activate costimulations pathways that further enhance T cell responses. SPE-C appears to achieve the same end but by a different mechanism, dispensing with the generic or-chain binding site in favor of a preformed dimer molecule with two zinc-containing [3-chain binding sites. The trade-off would appear to be a reduced TCR repertoire because, like TSST, only human V[32-bearing T cells are ligated by SPE-C (30). Nevertheless, this does not appear to affect the potency of SPE-C in vitro, at least towards human T cells. One major difference between SPE-C and TSST is that although TSST is extremely potent towards routine T cells, particularly murine V[315, SPE-C is completely inactive on murine T cells despite continued strong binding to the I-E molecule. The simplest explanation for this is that there are simply no mouse V[3s ligated by SPE-C. We find this surprising given the conservation of function of all other bacterial superantigens across species and the fact that SPE-C binding to mufine class II (I-E) is conserved.
The location of the TCR binding site on SPE-C has not been identified. Given the similarities between SPE-C and TSST in both folding and V[3 specificity, it is likely that the TCR binding site on SPE-C is located in a similar position to TSST along the main COOH-terminal domain o~ helix (11, 13, 31) rather than in the shallow groove between the COOH-and NH2-terminal domains as has been mapped for SEA, SEB, or SEC3. Analogous residues in SPE-C to those that form the murine V[38.2 TCR binding site of SEC3 (32) partially overlap the SPE-C dimer interface and would not be available for TCR ligation in the timer molecule (23) .
Confirmation that the SPE-C dimer is required for optimal activity at normal toxins concentrations (i.e., in the picomolar range) must await mutational analysis, but in its absence, the functional and biochemical studies presented here combined with the recent crystal structure of SPE-C propose an intriging model of SPE-C as a preformed dimer with two MHC class II [3-chain binding sites strategically placed at opposite poles to cross-link MHC class II, and potentially two TCR binding sites that might also induce cross-hnking of the TCR. This study reveals yet another potential mechanism of bacterial superantigens and highfights the variation that has developed in this family of potent T cell mitogens, despite conservation around a similar protein fold and continued targeting of the MHC class II molecule as the primary cell surface receptor.
